相关实验视频

Updated: Jan 10, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

通过PROteolysis-TTargeting Chimeras (PROTACs) 准蛋白氨酸酸酶:目前的发展和前景

Rosanna Maccari¹

¹Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy.

Molecules (Basel, Switzerland)

|November 27, 2025

概括

蛋白氨酸酸酶 (PTPs) 是关键酶,与疾病有关. 新的PROteolysis-TTargeting Chimeras (PROTACs) 提供了一个有前途的策略,用于向PTP降解,克服了以前的药物开发挑战.

科学领域:

生物化学和分子生物学
药用化学医学化学
药物发现药物发现药物发现

背景情况:

蛋白氨酸酸酶 (PTPs) 是调节细胞功能的关键酶.
PTP失调与癌症,糖尿病和神经退行性疾病等主要人类疾病有关.
针对PTP提供治疗潜力,但面临着重大药物开发障碍.

研究的目的:

探索 PROTEOLYSIS-TARGETING CHIMERAS (PROTACs) 在 PTP 抑制方面的潜力.
评估PROTACs作为PTP相关疾病的替代治疗策略.
突出开发针对 PTP 的 PROTAC 的优势和挑战.

主要方法:

审查目前用于PTP向的药物化学方法.
专注于PROTACs针对向蛋白质降解的新兴战略.
对针对PTP的PROTAC现有文献和初步数据的分析.

主要成果:

PROTACs代表了一种通过有针对性的降解来控制PTPs的新机制.
这种方法为传统的PTP抑制剂提供了一个有希望的替代方案.
早期的结果表明了针对PTP的PROTAC的可行性和潜力.

结论:

通过创新策略,如PROTACs,可以提高PTP的药物可用性.
PROTACs为开发针对PTP相关疾病的新疗法提供了一个有希望的途径.
需要进一步的研究来克服挑战,并推进针对PTP的PROTAC开发.

关键词:

这就是 PROTACs.癌症癌症癌症癌症癌症糖尿病糖尿病患者糖尿病患者蛋白质氨酸酸酶是一种蛋白质氨酸酸酶.有针对性的蛋白质降解降解.

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...